Glucose Control Lowers the Risk of Wound Infection in Diabetics After Open Heart Operations
|
|
- Raymond Walsh
- 8 years ago
- Views:
Transcription
1 Glucose Control Lowers the Risk of Wound Infection in Diabetics After Open Heart Operations Kathryn J. Zerr, MBA, Anthony P. Furnary, MD, Gary L. Grunkemeier, PhD, Stephen Bookin, MD, Vivek Kanhere, MD, and Albert Starr, MD Albert Starr Academic Center for Cardiac Surgery, Providence St. Vincent Hospital & Medical Center, Portland, Oregon Background. Elevated blood glucose levels in the postoperative period are associated with an increased risk of deep wound infection in diabetic individuals undergoing open heart operations at Providence St. Vincent Hospital. Methods. Of 8,910 patients who underwent cardiac operations between 1987 and 1993, 1,585 (18%) were diabetic. The rate of deep sternal wound infections in diabetic patients was 1.7%, versus 0.4% for nondiabetics. Nine hundred ninety patients had their operation before implementation of the protocol and 595 after implementation. Charts of all diabetic patients were reviewed. Mean blood glucose levels were calculated from documented results of finger-stick glucometer testing. Results. Thirty-three diabetic patients suffered 35 deep wound infections: 27 sternal (1.7%) and eight at the donor site (0.5%). Infected diabetic patients had a higher mean blood glucose level through the first 2 postoperative days than noninfected patients (208 ± 7.1 versus 190 ± 0.8 mg/dl; p < 0.003) and had a greater body mass index (31.5 ± 1.4 versus 28.6 ± 0.1 kg/m 2 ; p < 0.05). Multivariable logistic regression showed that mean blood glucose level for the first 2 days (p = 0.002), obesity (p < 0.002), and use of the internal mammary artery (p < 0.02) were all independent predictors of deep wound infection. Institution of a protocol of postoperative continuous intravenous insulin to maintain blood glucose level less than 200 mg/dl was begun in September This protocol resulted in a decrease in blood glucose levels for the first 2 postoperative days and a concomitant decrease in the proportion of patients with deep wound infections, from 2.4% (24/990) to 1.5% (9/595) (p < 0.02). Conclusions. The incidence of deep wound infection in diabetic patients was reduced after implementation of a protocol to maintain mean blood glucose level less than 200 mg/dl in the immediate postoperative period.
2 Introduction Intensive diabetic therapy with improved blood glucose control has been shown to delay the longterm detrimental effects of microvascular complications [1] and to prevent impairment of the white blood cell s ability to phagocytose and effectively kill bacteria [2, 3]. The importance of defects in leukocyte function in diabetics was addressed in 1982 by Rayfield and associates [4] at the Mount Sinai Medical Center, when they showed a significant positive correlation between mean plasma glucose levels and the frequency of acute infections. The diminution of intracellular bactericidal activity of leukocytes to both Staphylococcus aureus and Escherichia coli was shown to have a direct relation to glucose control. Studies by Hennessy and colleagues [5] at the University of Texas Medical School showed the detrimental effects of short-term hyperglycemia on the ability of immunoglobulin G to fix complement, one aspect of antimicrobial immune function. Of importance, their studies showed significant increases in glycation after only 16 hours [5]. The same group demonstrated that pretreatment of human immunoglobulin with 240 mg of glucose per deciliter of saline solution for as short as 8 hours under physiologic conditions stops its ability to extend survival in an asplenic, infant rat model [6]. Further, extracellular glycosylation of proteins in diabetics has been shown to impair wound healing and is associated with increased collagenase activity and decreased wound collagen content [7]. 2 Material and Methods Clinical Methods A diabetic protocol (Appendix 1) was designed and implemented that standardized the titration of intravenous insulin to maintain the mean blood glucose (BG) level less than 200 mg/dl. Blood glucose levels were determined by glucometer measurements, and insulin was titrated by critical care nurses. There were no changes in antibiotic protocols during this time, and procedures were performed by the same surgical group. Data were collected by retrospective chart review on all diabetic patients who had cardiac operations between 1987 and 1993 at Providence St. Vincent Hospital. Table 1 shows baseline data for the patients before and after implementation of the protocol. Daily mean BG levels were calculated by averaging the levels obtained clinically by finger stick every 1 to 2 hours and were recorded in the medical record. Levels were compared before and after implementation of the diabetic patients with deep wound infections were compared with those who did not become infected (Fig 2).
3 Table 1. Comparison of Patients Before and After Implementation of the Diabetic Protocol Before After Protocol Protocol Variable (n = 990) (n = 595) Not found significant ( p > 0.05) Age Sex male 62% 60% Weight (kg) Smoked within 30 d of operation 17% 13% Renal failure 6% 8% Peripheral vascular disease 14% 15% Diabetes type Insulin dependent 35% 38% Oral agent 49% 47% Diet only 11% 10% No treatment 6% 6% Procedure CABG without IMA 32% 33% CABG with IMA 56% 54% Valve only 7% 7% Valve plus CABG 5% 6% Other 1% 1% Redo operation 14% 13% Pump time (min) Ventilator > 48 h 8% 11% Inotropic agents > 48 h 14% 11% Mortality 6% 5% Significant (p < 0.05) History of hypertension 54% 64% History of congestive heart failure 28% 23% Renal insufficiency 3% 6% Status at operation Elective 49% 22% Urgent 43% 68% Emergent 6% 7% Salvage 3% 2% Body mass index (kg/cm2) CABG = coronary artery bypass grafting; IMA = internal mammary artery. 3
4 4 Statistical Methods Multiple variables were considered as possible predictors of deep wound infection. Variables and their univariate significance were as follows: body mass index, ; average BG 48 hours after operation, ; mean BG level on first postoperative day, 0.003; mean BG level on second postoperative day, ; use of internal mammary artery, ; operation before or after protocol implemented, 0.077; inotropic agents for more than 48 hours, ; body surface area, ; diabetes requiring insulin or oral agents, ; redo operation, ; status at time of operation, ; packed red blood cells transfused, ; steroids, ; sex, ; age, ; and pump time, Univariate and multiple logistic regression analyses were used to develop a model to predict the risk of deep wound infection for each patient. Analysis was done by paired t test, X 2 test, and multivariable logistic regression using SPSS (Chicago, IL) statistical software. Definitions were as follows: Body mass index = weight/height 2 ; body surface area = body weight x height x (Dubois equation); obesity = body mass index greater than Deep wound infection included mediastinitis, sternal wound infections involving the sternum and deeper, and vein donor-site infections involving Scarpa s fascia and deeper. Diabetic patients included those who were insulin dependent and non insulin-dependent at the time of operation. We excluded patients who were not diabetic but temporarily required insulin in the postoperative period related to the administration of total parenteral nutrition or inotropic agents (i.e., epinephrine), and who did not require therapy after the discontinuation of these treatments. Elective status at operation denoted one that was performed on a patient with cardiac function that had been stable in the days or weeks before operation. Cases are usually scheduled at least 1 day before the surgical procedure. Urgent status at operation included any patient who did not have to go to the operating room emergently but required operation on the basis of medical necessity before discharge. These patients had unstable symptoms or critical anatomy and often required intravenous intervention, ie, nitroglycerin, heparin, or inotropic support, for stabilization before operation. These patients did not fit into the elective, emergent or salvage categories. Emergent status at operation denoted cases that permitted no delay in operative intervention. Patients requiring emergency operation had ongoing, refractory, unrelenting cardiac compromise, with or without hemodynamic instability, and were not responsive to any form of therapy except cardiac operation. Salvage status at operation involved any patient in extremis or in cardiogenic shock going into the operating room. This included patients who came to the operating room with cardiopulmonary resuscitation in
5 5 progress. Renal insufficiency was defined as physician-documented renal insufficiency or patients with an increase in the creatinine level to greater than 2.0 mg/dl. Clinical Material In all, 8,910 patients underwent cardiac operations between 1987 and 1993; 1,585 were diabetic (18%): 35% insulin dependent, 47% taking oral agents, 10% diet controlled, and 6% on no treatment before admission. The mean age was 65 ± 9.7 years; 61% (963/1,585) were male. There were 1,378 coronary artery bypass grafting operations (63% using the internal mammary artery), 110 valve operations, 84 valve/coronary artery bypass grafting, and 12 other operations; 213 (14%) were redosternotomies. The overall mortality rate in the diabetic population was 5.7% (90/1,585). Thirty-three patients suffered 35 deep wound infections (2.1%): sternal in 27 and donor in eight. Of those patients who died, 6.7% (6/90) had deep wound infection. Of 33 patients who had deep wound infections, 6 died (18%). Diabetic patients who were admitted with endocarditis (n = 6) were included, but none of them had deep wound infection. Fig 1. Mean blood glucose levels in all diabetic patients before and after implementation of the diabetic protocol.
6 6 Results Implementation of the diabetic protocol in September 1991 resulted in a decrease in the mean BG levels on the first postoperative day (206 versus 172 mg/dl; p < 0.005) and the second postoperative day (195 versus 176 mg/dl; p < 0.002) (see Fig 1), and over 48 hours (201 versus 174 mg/dl; p < 0.003). Glucose levels were measured by glucometer tests, as indicated in the protocol (see Appendix 1). The rate of deep sternal wound infection in diabetic patients dropped from 2.8% in 1987 to 0.74% in 1993, the third year after implementation. When measured over a 5-year period before implementation of the diabetic protocol, the rate in diabetic patients was 2.1% versus 0.98% in the 3 years after implementation. In nondiabetic patients, the 5-year rate was 0.4%, versus 0.31% for the 3 years after implementation. Elevated BG at 48 hours was found to be significantly associated with an increased risk of deep wound infection (p < 0.002) (see Fig 2; Fig 3). When looked at over time, the rate of infection in diabetic patients dropped after implementation of the diabetic protocol (Fig 4). Univariate regression analysis of variables considered as possible predictors of deep wound infection in diabetic patients revealed the following to be significant at p < internal mammary artery. Variables in the multivariable 0.05: body mass index, average BG at 48 hours, BG on the predictive model found to be significant at p < 0.05 were first and second postoperative days, and use of the body mass index, use of the internal mammary artery, and mean BG levels at 48 hours greater than 200 mg/dl (Table 2). Postoperative BG and the deep wound infection rate showed a significant direct relation (p = 0.002) (Fig 5). This model demonstrates the ability to identify diabetic patients at higher risk of deep wound infection after cardiac operations (Fig 6). Fig 2. Comparison of mean blood glucose levels in diabetic patients (Pts) with and without deep wound infection (includes mediastinitis, sternal wound infections involving the sternum and deeper, and vein donor-site infections involving Scarpa s fascia and deeper).
7 7 Fig 3. Mean blood glucose levels on the first postoperative day (POD) for patients with deep wound infection and for all patients. Fig 4. Deep sternal wound infection (DSWI) in patients having cardiac operations: all patients versus diabetic patients versus nondiabetic patients.
8 Table 2. Variables in the Final Predictive Model Significant at p < 0.05 a 8 Regression Standard Variable Coefficient Error Significance Body mass index (BMI) Internal mammary artery (IMA) Average blood glucose levels 48 h after operation (BG48) a Probability of deep wound infection = e BX /1 + e BX, where BX = x IMA x BG48. Model provides an estimate of the risk of deep wound infection for each diabetic patient having cardiac operation. Fig 5. Significant direct relation shown between postoperative blood glucose level and deep infection rates. Fig 6. Reliability of the model to assign appropriate risk is shown by comparing groups according to the expected risk of infection versus actual infection rates.
9 9 Comment Deep wound infection causes increased mortality, lengthy hospital stays, repeated trips to the operating room, and greater hospital costs, not to mention the pain and suffering of patients and their families during prolonged convalescence. It is well documented that an increased body mass index (measure of obesity) [8, 9] increases the risk of infection. Reports of increased risk with use of the internal mammary artery have differed and occasionally conflict among institutions [10 12]. What has not been shown in clinical practice is the effect of intensive control of BG levels in diabetic patients in the postoperative period. We hypothesize that elevated BG levels after cardiac operations in diabetic patients are associated with a higher incidence of infectious complications. The 5-year rate of deep wound infection in patients having cardiac operations at Providence St. Vincent Hospital & Medical Center was six times higher in diabetics than in nondiabetics. The diabetic protocol was proven successful in lowering the mean BG levels in the immediate postoperative period (see Fig 1). The decrease in infection rates for patients with average BG levels less than 200 mg/dl on the first postoperative day was significant (p = 0.018). The rate of deep sternal wound infection in diabetics has decreased since implementation of the protocol, whereas the rate in nondiabetic patients remains stable at less than 1%; this shows that the decrease is likely not due to other factors. This was an observational study using retrospective chart review. We recognize the inherent problems of lack of recognition of important variations among patient populations and the potential bias to which this type of investigation may be prone. However, we believe that the significant impact on mean BG levels with use of the protocol is a determining factor in the dramatic decrease in our infection rates. We are confident that the decreased rates before and after implementation of the protocol (p = 0.14) will show higher significance as more patients are added to the study (see Fig 3). In conclusion, elevated BG levels immediately after cardiac operations in diabetic patients in our study were associated with a higher incidence of deep wound infection. We suggest that protocols for maintaining BG less than 200 mg/dl in the immediate postoperative period may be a factor in reducing the incidence of deep wound infection in diabetic patients. We thank Kenneth Melvin, MD, Endocrinologist and Chief of Medicine, and Peter Fuchs, MD, Director of Laboratory and Hospital Epidemiologist, for their guidance, advice, and support; and Stephanie Zerr for data management support. Address reprint requests to Ms Zerr, Providence St. Vincent Hospital & Medical Center, 9205 SW Barnes Rd, Portland, OR
10 10 References 1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in in-sulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329: Sima AA, O Neill SJ, Naimark D, Yagihashi S, Klass D. Bacterial phagocytosis and intracellular killing by alveolar macrophages in BB rats. Diabetes 1988;37: Masuda M, Murakami T, Egawa H, Murata K. Decreased fluidity of polymorphonuclear leukocyte membrane in strep-tozocin-induced diabetic rats. Diabetes 1990;39: Rayfield EJ, Ault MJ, Keusch GT, et al. Infection and diabetes: the case for glucose control [Review]. Am J Med 1982;72: Hennessey PJ, Black CT, Andrassy RJ. Nonenzymatic glycosylation of immunoglobulin G impairs complement fixation. JPEN J Parenter Enteral Nutr 1991;15: Black CT, Hennessey PJ, Andrassy RJ. Short-term hyperglycemia depresses immunity through nonenzymatic glycosylation of circulating immunoglobulin. J Trauma 1990;30: Hennessey PJ, Ford EG, Black CT, Andrassy RJ. Wound collagenase activity correlates directly with collagen glycosylation in diabetic rats. J Pediatr Surg 1990;25: Gadaleta D, Risucci DA, Nelson RL, et al. Effects of morbid obesity and diabetes mellitus on risk of coronary artery bypass grafting. Am J Cardiol 1992;70: He G-W, Ryan WH, Acuff TE, et al. Risk factors for operative mortality and sternal wound infection in bilateral internal mammary artery grafting. J Thorac Cardiovasc Surg 1991; 102: Grossi EA, Esposito R, Harris LJ, et al. Sternal wound infections and use of internal mammary artery grafts. J Thorac Cardiovasc Surg 1991;102: Singh AK, Feng WC. Sternal wound infection after myocardial revascularization with internal mammary artery. Indian Heart J 1993;45: Lust RM, Sun YS, Chitwood WR Jr. Internal mammary artery use. Sternal revascularization and experimental infection patterns. Circulation 1991;84(Suppl 3):
11 11 Appendix 1. Postoperative Insulin Protocol for Diabetic Patients 1. Start infusion by pump piggyback to maintenance intravenous line as follows. Test blood glucose by finger-stick method. Blood glucose level (in mg/dl) determines insulin rate: <150, 0 U/h; , 1 U/h; , 2 U/h; >251, 3 U/h. 2. Frequency of blood glucose testing: (a) postoperatively every hour until stable (when frequent changes in insulin dosage are no longer necessary), then may test every 2 hours; (b) when weaning vasopressor agents (eg, adrenalin), check every 30 minutes until stable. 3. Insulin titration based on blood glucose level (in mg/dl): (a) <75 stop insulin, give 25 ml D 50 and recheck blood glucose in 30 minutes; when blood glucose >150 mg/dl, restart with rate 50% of previous rate; (b) stop insulin; recheck blood glucose in 30 minutes; when blood glucose >150 mg/dl, restart with rate 50% of previous rate; (c) decrease rate by 0.5 U/h or, if 10 mg/dl lower than last test, decrease rate by 50%; (d) same rate; (e) if lower than last test, same rate; if higher than last test, increase rate by 0.5 U/h; and (f) >250 if lower than last test, same rate; if higher than last test, increase rate by 1 U/h. If blood glucose is >251 mg/dl and has not decreased after three hourly increases in insulin, then double the insulin rate. 4. Continue intravenous insulin administration postoperatively until patient is taking a full liquid diet. Consult MD for new orders at that time. 5. Diabetic diet starts with any oral intake.
Denominator Statement: Cardiac surgery patients with no evidence of prior infection.
Last Updated: Version 4.3b NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Information Form CMS/The Joint Commission: Suspended (Effective immediately beginning with July 1, 2014 discharges)
More informationImplementing The Portland Protocol - Continuous Intravenous Insulin Infusion in your institution
Implementing The Portland Protocol - Continuous Intravenous Insulin Infusion in your institution Anthony P. Furnary, MD St Vincent Medical Center Providence Health Systems Portland, OR Phased Implementation
More informationDepartment of Pharmacy, Kaiser Permanente San Francisco Medical Center, San Francisco 94115, California, USA
Journal of Pharmacy and Pharmacology 3 (2015) 33-38 doi: 10.17265/2328-2150/2015.01.005 D DAVID PUBLISHING Evaluation of Glycemic Control with a Pharmacist-Managed Post-Cardiothoracic Surgery Insulin Protocol
More informationOmega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine April 2006;34(4):972-9
Omega-3 fatty acids improve the diagnosis-related clinical outcome 1 Critical Care Medicine April 2006;34(4):972-9 Volume 34(4), April 2006, pp 972-979 Heller, Axel R. MD, PhD; Rössler, Susann; Litz, Rainer
More informationMANAGEMENT OF HYPERGLYCEMIA IN CRITICALLY ILL SURGICAL PATIENTS
DISCLAIMER: These guidelines were prepared by the Department of Surgical Education, Orlando Regional Medical Center. They are intended to serve as a general statement regarding appropriate patient care
More informationGlycemic Control of Type 2 Diabetes Mellitus
Bahrain Medical Bulletin, Vol. 28, No. 3, September 2006 Glycemic Control of Type 2 Diabetes Mellitus Majeda Fikree* Baderuldeen Hanafi** Zahra Ali Hussain** Emad M Masuadi*** Objective: To determine the
More informationCARDIAC SURGERY INTRAVENOUS INSULIN PROTOCOL PHYSICIAN ORDERS INDICATIONS EXCLUSIONS. Insulin allergy
Page 1 of 5 INDICATIONS EXCLUSIONS 2 consecutive blood glucose measurements greater than 110 mg per dl AND NPO with a continuous caloric source AND Diagnosis of : Cardio-thoracic Surgery NOTE: This protocol
More informationRecommendations: Other Supportive Therapy of Severe Sepsis*
Recommendations: Other Supportive Therapy of Severe Sepsis* K. Blood Product Administration 1. Once tissue hypoperfusion has resolved and in the absence of extenuating circumstances, such as myocardial
More informationListen to your heart: Good Cardiovascular Health for Life
Listen to your heart: Good Cardiovascular Health for Life Luis R. Castellanos MD, MPH Assistant Clinical Professor of Medicine University of California San Diego School of Medicine Sulpizio Family Cardiovascular
More informationPrognostic impact of uric acid in patients with stable coronary artery disease
Prognostic impact of uric acid in patients with stable coronary artery disease Gjin Ndrepepa, Siegmund Braun, Martin Hadamitzky, Massimiliano Fusaro, Hans-Ullrich Haase, Kathrin A. Birkmeier, Albert Schomig,
More informationCLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014
CLINICAL QUALITY MEASURES FINALIZED FOR ELIGIBLE HOSPITALS AND CRITICAL ACCESS HOSPITALS BEGINNING WITH FY 2014 e 55 0495 2 Emergency Department (ED)- 1 Emergency Department Throughput Median time from
More informationObjectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History
Preoperative Cardiac Risk Stratification for Noncardiac Surgery Kimberly Boddicker, MD FACC Essentia Health Heart and Vascular Center 27 th Heart and Vascular Conference May 13, 2011 Objectives Summarize
More informationImproving Glycemic Control for Post-Operative Cardiac Surgery Patients: A Nurse Practitioner Led Project. Linda Kerr, DNP, RN, FNP-BC, CDE
Improving Glycemic Control for Post-Operative Cardiac Surgery Patients: A Nurse Practitioner Led Project Linda Kerr, DNP, RN, FNP-BC, CDE Problem Statement Hyperglycemia during the first 48 hours following
More informationINTERNAL MEDICINE RESIDENTS NOON CONFERENCE: INPATIENT GLYCEMIC CONTROL
INTERNAL MEDICINE RESIDENTS NOON CONFERENCE: INPATIENT GLYCEMIC CONTROL Presented by: Leyda Callejas PGY5 Endocrinology, Diabetes and Metabolism Acknowledgements: Dr. P Orlander Dr. V Lavis Dr. N Shah
More informationINPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco
INPATIENT DIABETES MANAGEMENT Robert J. Rushakoff, MD Professor of Medicine Director, Inpatient Diabetes University of California, San Francisco CLINICAL RECOGNITION Background: Appropriate inpatient glycemic
More informationTherapeutic Approach in Patients with Diabetes and Coronary Artery Disease
Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,
More informationElevated heart rate at twelve months after heart transplantation is an independent predictor of long term mortality
Elevated heart rate at twelve months after heart transplantation is an independent predictor of long term mortality C. Tomas, MA Castel, E Roig, I. Vallejos, C. Plata, F. Pérez-Villa Cardiology Department,
More informationTYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION. Robert Dobbins, M.D. Ph.D.
TYPE 2 DIABETES MELLITUS: NEW HOPE FOR PREVENTION Robert Dobbins, M.D. Ph.D. Learning Objectives Recognize current trends in the prevalence of type 2 diabetes. Learn differences between type 1 and type
More informationTuberculosis And Diabetes. Dr. hanan abuelrus Prof.of internal medicine Assiut University
Tuberculosis And Diabetes Dr. hanan abuelrus Prof.of internal medicine Assiut University TUBERCULOSIS FACTS More than 9 million people fall sick with tuberculosis (TB) every year. Over 1.5 million die
More informationInpatient Treatment of Diabetes
Inpatient Treatment of Diabetes Alan J. Conrad, MD Medical Director Diabetes Services EVP, Physician Alignment Diabetes Symposium November 12, 2015 Objectives Explain Palomar Health goals for inpatient
More information8-9-2012. In hospital diabetes care background and challenges. Duality of interest. One of the goals may be...
In hospital diabetes care background and challenges Duality of interest Nothing to disclose within the framework of this presentation My own fasting BG is 4.6 mmol/l, HbA1c 5.4% Bruce H.R. Wolffenbuttel
More informationWeight Loss Surgery DA participants- 18 months later. By: Caitlyn Patrick and Evan Morgan
Weight Loss Surgery DA participants- 18 months later By: Caitlyn Patrick and Evan Morgan Outline Background Obesity Comorbidities Treatments Barriers to care Kylee Miller s work PDSA Plan: Systematic follow
More informationYour Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007
Your Life Your Health Cariodmetabolic Risk Syndrome Part VII Inflammation chronic, low-grade By James L. Holly, MD The Examiner January 25, 2007 The cardiometabolic risk syndrome is increasingly recognized
More information06 Validation of risk prediction model
HA Territory-wide PCI Audit 2003-06 06 Validation of risk prediction model PCI Audit Working Group Central Committee (Cardiac Services) HA Convention 2007 Background Participants: All HA hospitals via
More informationSepsis: Identification and Treatment
Sepsis: Identification and Treatment Daniel Z. Uslan, MD Associate Clinical Professor Division of Infectious Diseases Medical Director, UCLA Sepsis Task Force Severe Sepsis: A Significant Healthcare Challenge
More informationSection 2. Overview of Obesity, Weight Loss, and Bariatric Surgery
Section 2 Overview of Obesity, Weight Loss, and Bariatric Surgery What is Weight Loss? How does surgery help with weight loss? Short term versus long term weight loss? Conditions Improved with Weight Loss
More informationGuidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes
Guidance for Industry Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes U.S. Department of Health and Human Services Food and Drug Administration Center
More informationSponsor. Novartis Generic Drug Name. Vildagliptin. Therapeutic Area of Trial. Type 2 diabetes. Approved Indication. Investigational.
Clinical Trial Results Database Page 1 Sponsor Novartis Generic Drug Name Vildagliptin Therapeutic Area of Trial Type 2 diabetes Approved Indication Investigational Study Number CLAF237A2386 Title A single-center,
More informationThe Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery
The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery Michael E. Farkouh, MD, MSc Peter Munk Chair in Multinational Clinical Trials Director, Heart and Stroke
More informationFeeding in Infants with Complex Congenital Heart Disease. Rachel Torok, MD Southeastern Pediatric Cardiology Society Conference September 6, 2014
Feeding in Infants with Complex Congenital Heart Disease Rachel Torok, MD Southeastern Pediatric Cardiology Society Conference September 6, 2014 Objectives Discuss common feeding issues in patients with
More informationThe Cardiac Society of Australia and New Zealand
The Cardiac Society of Australia and New Zealand Guidelines on Support Facilities for Coronary Angiography and Percutaneous Coronary Intervention (PCI) including Guidelines on the Performance of Procedures
More informationNova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines)
Cardiovascular Health Nova Scotia Guideline Update Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines) Authors: Dr. M. Love, Kathy Harrigan Reviewers:
More informationEndoskopische Venenentnahme der V. saphena in der koronaren Bypasschirurgie - Aktuelle Datenlage - Dr. med. Stefanie Reutter
Endoskopische Venenentnahme der V. saphena in der koronaren Bypasschirurgie - Aktuelle Datenlage - Dr. med. Stefanie Reutter Endoskopische Venenentnahme (EVH) - Einführung 1979 Tevaearai und Kollegen haben
More informationAktuelle Literatur aus der Notfallmedizin
05.02.2014 Aktuelle Literatur aus der Notfallmedizin prä- und innerklinisch Aktuelle Publikationen aus 2012 / 2013 PubMed hits zu emergency medicine 12,599 Abstract OBJECTIVES: Current American Heart
More informationCilostazol versus Clopidogrel after Coronary Stenting
Cilostazol versus Clopidogrel after Coronary Stenting Seong-Wook Park, MD, PhD, FACC Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine Seoul, Korea AMC, 2004 Background
More informationDiabetes Expert Witness on: Diabetic Hypoglycemia in Nursing Homes
Diabetes Expert Witness on: Diabetic Hypoglycemia in Nursing Homes Nursing home patients with diabetes treated with insulin and certain oral diabetes medications (i.e. sulfonylureas and glitinides) are
More informationDiabetes mellitus. Lecture Outline
Diabetes mellitus Lecture Outline I. Diagnosis II. Epidemiology III. Causes of diabetes IV. Health Problems and Diabetes V. Treating Diabetes VI. Physical activity and diabetes 1 Diabetes Disorder characterized
More informationCENTER FOR DRUG EVALUATION AND RESEARCH
CENTER FOR DRUG EVALUATION AND RESEARCH APPLICATION NUMBER: 205029Orig1s000 SUMMARY REVIEW Cross Discipline Team Leader Review 4. Nonclinical Pharmacology/Toxicology In their review of the original application,
More informationCSII (CONTINUOUS SUBCUTANEOUS INSULIN INFUSION) AND INPATIENT ADMISSION
CSII (CONTINUOUS SUBCUTANEOUS INSULIN INFUSION) AND INPATIENT ADMISSION Goals of Inpatient Glucose Management Avoid Hypoglycemia (Serum glucose
More informationNutrition. Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT
1 Nutrition Type 2 Diabetes: A Growing Challenge in the Healthcare Setting NAME OF STUDENT 2 Type 2 Diabetes: A Growing Challenge in the Healthcare Setting Introduction and background of type 2 diabetes:
More informationPerioperative Cardiac Evaluation
Perioperative Cardiac Evaluation Caroline McKillop Advisor: Dr. Tam Psenka 10-3-2007 Importance of Cardiac Guidelines -Used multiple times every day -Patient Safety -Part of Surgical Care Improvement Project
More informationTreatment of diabetes In order to survive, people with type 1 diabetes must have insulin delivered by a pump or injections.
National Diabetes Statistics What is diabetes? Diabetes mellitus is a group of diseases characterized by high levels of blood glucose resulting from defects in insulin production, insulin action, or both.
More informationMedical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South
Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains
More informationECG may be indicated for patients with cardiovascular risk factors
eappendix A. Summary for Preoperative ECG American College of Cardiology/ American Heart Association, 2007 A1 2002 A2 European Society of Cardiology and European Society of Anaesthesiology, 2009 A3 Improvement,
More informationOpen and Honest Care in your Local Hospital
Open and Honest Care in your Local Hospital The Open and Honest Care: Driving Improvement Programme aims to support organisations to become more transparent and consistent in publishing safety, experience
More informationMethods for Delivering Insulin and Monitoring Blood Sugar. A Review of the Research for Children, Teens, and Adults With Diabetes
Methods for Delivering Insulin and Monitoring Blood Sugar A Review of the Research for Children, Teens, and Adults With Diabetes Is This Information Right for Me? Yes, if: Your doctor* has told you that
More informationAll Intraosseous Sites Are Not Equal
All Intraosseous Sites Are Not Equal Clinical Data Suggests the Sternal IO Route Improves Patient Outcomes Current Guidelines, (such as AHA) indicate that Intraosseous Infusion (IO) is a rapid, safe and
More informationCoronary Heart Disease (CHD) Brief
Coronary Heart Disease (CHD) Brief What is Coronary Heart Disease? Coronary Heart Disease (CHD), also called coronary artery disease 1, is the most common heart condition in the United States. It occurs
More informationQuiz 5 Heart Failure scores (n=163)
Quiz 5 Heart Failure summary statistics The correct answers to questions are indicated by *. Students were awarded 2 points for question #3 for either selecting spironolactone or eplerenone. However, the
More informationSubstandard Underwriting Structured Settlements
Substandard Underwriting Structured Settlements Structures 101-Back to Basics February 20-22, 2013 Las Vegas, Nevada Rosemary Brindamour BSN CSSC Chief Medical Underwriter Structured Settlement Underwriting
More informationKIH Cardiac Rehabilitation Program
KIH Cardiac Rehabilitation Program For any further information Contact: +92-51-2870361-3, 2271154 Feedback@kih.com.pk What is Cardiac Rehabilitation Cardiac rehabilitation describes all measures used to
More informationPREOPERATIVE MANAGEMENT FOR BARIATRIC PATIENTS. Adrienne R. Gomez, MD Bariatric Physician St. Vincent Bariatric Center of Excellence
PREOPERATIVE MANAGEMENT FOR BARIATRIC PATIENTS Adrienne R. Gomez, MD Bariatric Physician St. Vincent Bariatric Center of Excellence BARIATRIC SURGERY Over 200,000 bariatric surgical procedures are performed
More informationSteven J. Yakubov, MD FACC For the CoreValve US Clinical Investigators
Long-Term Outcomes Using a Self- Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Deemed Extreme Risk for Surgery: Two-Year Results From the CoreValve US Pivotal Trial Steven J. Yakubov,
More informationLothian Diabetes Handbook MANAGEMENT OF DIABETIC KETOACIDOSIS
MANAGEMENT OF DIABETIC KETOACIDOSIS 90 MANAGEMENT OF DIABETIC KETOACIDOSIS Diagnosis elevated plasma and/or urinary ketones metabolic acidosis (raised H + /low serum bicarbonate) Remember that hyperglycaemia,
More informationOverview of Diabetes Management. By Cindy Daversa, M.S.,R.D.,C.D.E. UCI Health
Overview of Diabetes Management By Cindy Daversa, M.S.,R.D.,C.D.E. UCI Health Objectives: Describe the pathophysiology of diabetes. From a multiorgan systems viewpoint. Identify the types of diabetes.
More informationCME Test for AMDA Clinical Practice Guideline. Diabetes Mellitus
CME Test for AMDA Clinical Practice Guideline Diabetes Mellitus Part I: 1. Which one of the following statements about type 2 diabetes is not accurate? a. Diabetics are at increased risk of experiencing
More informationSeptic Shock: Pharmacologic Agents for Hemodynamic Support. Nathan E Cope, PharmD PGY2 Critical Care Pharmacy Resident
Septic Shock: Pharmacologic Agents for Hemodynamic Support Nathan E Cope, PharmD PGY2 Critical Care Pharmacy Resident Objectives Define septic shock and briefly review pathophysiology Outline receptor
More informationContinuous Insulin Infusions Reduce Mortality in Diabetic CABG patients
Continuous Insulin Infusions Reduce Mortality in Diabetic CABG patients Anthony P. Furnary 1,4, MD; Guangqiang Gao 1, MD; Gary L. Grunkemeier 2, PhD; YingXing Wu, MD 2 ; Kathryn J. Zerr 2, MBA; Stephen
More informationOpen Ventral Hernia Repair
Ventral Hernias Open Ventral Hernia Repair UCSF Postgraduate Course in General Surgery Maui, HI March 21, 2011 Hobart W. Harris, MD, MPH Ventral Hernias: National Experience Occur following 11-23% of laparotomies,
More informationIntensive Glucose Management in Critically Ill Patients Improves Patient Outcomes
PHARMACY PRACTICE PAPER Intensive Glucose Management in Critically Ill Patients Improves Patient Outcomes Nora Padilla, RPh University of Florida Working Professional Doctor of Pharmacy Program Spring
More informationScottish Diabetes Survey 2013. Scottish Diabetes Survey Monitoring Group
Scottish Diabetes Survey 2013 Scottish Diabetes Survey Monitoring Group Contents Contents... 2 Foreword... 4 Executive Summary... 6 Prevalence... 8 Undiagnosed diabetes... 18 Duration of Diabetes... 18
More informationType 1 Diabetes ( Juvenile Diabetes)
Type 1 Diabetes W ( Juvenile Diabetes) hat is Type 1 Diabetes? Type 1 diabetes, also known as juvenile-onset diabetes, is one of the three main forms of diabetes affecting millions of people worldwide.
More informationHow can registries contribute to guidelines? Nicolas DANCHIN, HEGP, Paris
How can registries contribute to guidelines? Nicolas DANCHIN, HEGP, Paris Pros and cons of registers Prospective randomised trials constitute the cornerstone of "evidence-based" medicine, and they therefore
More informationTHE STATISTICAL VARIANCE OF BLOOD GLUCOSE LEVELS OF MEDICIAL INTENSIVE CARE UNIT PATIENTS WHILE ON AN INSULIN INFUSION PROTOCOL
THE STATISTICAL VARIANCE OF BLOOD GLUCOSE LEVELS OF MEDICIAL INTENSIVE CARE UNIT PATIENTS WHILE ON AN INSULIN INFUSION PROTOCOL by Kimberly Lynn Ackerman A thesis submitted in partial fulfillment of the
More informationCHAPTER V DISCUSSION. normal life provided they keep their diabetes under control. Life style modifications
CHAPTER V DISCUSSION Background Diabetes mellitus is a chronic condition but people with diabetes can lead a normal life provided they keep their diabetes under control. Life style modifications (LSM)
More informationThe Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome
Biomedical & Pharmacology Journal Vol. 6(2), 259-264 (2013) The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome Vadod Norouzi 1, Ali
More informationCORONARY ARTERY BYPASS GRAFT & HEART VALVE SURGERY
CORONARY ARTERY BYPASS GRAFT & HEART VALVE SURGERY www.cpmc.org/learning i learning about your health What to Expect During Your Hospital Stay 1 Our Team: Our cardiac surgery specialty team includes nurses,
More informationAfter acute myocardial infarction, diabetes CARDIAC OUTCOMES AFTER MYOCARDIAL INFARCTION IN ELDERLY PATIENTS WITH DIABETES MELLITUS
CARDIAC OUTCOMES AFTER MYOCARDIAL INFARCTION IN ELDERLY PATIENTS WITH DIABETES MELLITUS By Deborah Chyun, RN, PhD, Viola Vaccarino, MD, PhD, Jaime Murillo, MD, Lawrence H. Young, MD, and Harlan M. Krumholz,
More informationAttending Director, Division of Psychosomatic Medicine, Miyagi Chuou Hospital
Stress-related Diseases Diabetes Mellitus JMAJ 45(5): 197 21, 22 Yuichi YAMAUCHI Attending Director, Division of Psychosomatic Medicine, Miyagi Chuou Hospital Abstract: Diabetes mellitus is not a simple
More informationThe impact of a reduced dose of dexamethasone on glucose control after coronary artery bypass surgery.
The impact of a reduced dose of dexamethasone on glucose control after coronary artery bypass surgery. Mathijs Vogelzang*, Miriam Hoekstra*, José T. Drost, Marcel Janse, Iwan C. C. van der Horst, Piet
More informationThe State of the Liver in the Adult Patient after Fontan Palliation
The State of the Liver in the Adult Patient after Fontan Palliation Fred Wu, M.D. Boston Adult Congenital Heart Service Boston Children s Hospital/Brigham & Women s Hospital 7 th National Adult Congenital
More informationResults of streamlined regional ambulance transport and subsequent treatment of acute abdominal aortic aneurysm
CHAPTER 6 Results of streamlined regional ambulance transport and subsequent treatment of acute abdominal aortic aneurysm JW Haveman, A Karliczek, ELG Verhoeven, IFJ Tielliu, R de Vos, JH Zwaveling, JJAM
More informationCardiac Rehabilitation The Best Medicine for Your CAD Patients. James A. Stone
James A. Stone BPHE, BA, MSc, MD, PhD, FRCPC, FAACVPR, FACC Clinical Professor of Medicine, University of Calgary Total Cardiology, Calgary Acknowledgements and Disclosures Acknowledgements Jacques Genest
More informationDeborah Young, RN, BSN, CNOR Green Belt Charleston Area Medical Center
Deborah Young, RN, BSN, CNOR Green Belt Charleston Area Medical Center Charleston Area Medical Center Charleston, West Virginia 5,818 Employees 913 Licensed Beds 392 General Hospital 375 Memorial Hospital
More informationMonitoring surgical wounds for infection
Monitoring surgical wounds for infection Information for patients This leaflet explains surgical wound infection and the national programme for monitoring infections acquired in hospitals This hospital
More informationBARIATRIC SURGERY MAY CURE TYPE 2 DIABETES IN SOME PATIENTS
BARIATRIC SURGERY MAY CURE TYPE 2 DIABETES IN SOME PATIENTS Thomas Rogula MD, Stacy Brethauer MD, Bipand Chand MD, and Philip Schauer, MD. "Gastric bypass surgery has become a popular option for obese
More informationReducing Insulin Related Errors in Patients Treated for Hyperkalemia
Reducing Insulin Related Errors in Patients Treated for Hyperkalemia Tan Tock Seng Hospital is an acute care general hospital with a 1,200 bed capacity The hospital addressed the problem of insulinrelated
More information嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯
The Clinical Efficacy and Safety of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors in Adults with Type 2 Diabetes Mellitus 嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯 Diabetes Mellitus : A group of diseases characterized
More informationMain Effect of Screening for Coronary Artery Disease Using CT
Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,
More informationSECTION: NM NUMBER: 20. HENRY FORD HOSPITAL DETROIT, MICHIGAN TITLE: GLYCEMIC CONTROL INTENSIVE CARE PROTOCOL UNIT: All ICUs
CLINICALPROTOCOL MULTIDISCIPLINARY SECTION: NM NUMBER: 2 HENRY FORD HOSPITAL DETROIT, MICHIGAN TITLE: GLYCEMIC CONTROL INTENSIVE CARE PROTOCOL UNIT: All ICUs APPROVED: 3/3 REVIEWED: REVISED: 12/3, 5/,
More informationAdding IV Amiodarone to the EMS Algorithm for Cardiac Arrest Due to VF/Pulseless VT
Adding IV Amiodarone to the EMS Algorithm for Cardiac Arrest Due to VF/Pulseless VT Introduction Before the year 2000, the traditional antiarrhythmic agents (lidocaine, bretylium, magnesium sulfate, procainamide,
More informationPsoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis
Psoriasis Co-morbidities: Changing Clinical Practice Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology Psoriatic Arthritis Psoriatic Arthritis! 11-31% of patients with psoriasis have psoriatic
More informationElectronic copy to all appropriate staff Intranet Notification in Staff Focus Related Trust Policies (to be read in conjunction with)
Diabetes Management for Children and Young People undergoing Surgery (0-16 yrs) Clinical Guideline Register No: 10096 Status: Public Developed in response to: Updated national guidelines Contributes to
More informationAll patients presenting to the Emergency Department with symptoms suggestive of
APPENDIX: Online Data Supplements Clinical Trial Inclusion and Exclusion Criteria All patients presenting to the Emergency Department with symptoms suggestive of acute coronary syndrome (ACS) were screened
More informationHeart Center Packages
Heart Center Packages For more information and appointments, Please contact The Heart Center of Excellence at the American Hospital Dubai Tel: +971-4-377-6571 Email: heartcenter@ahdubai.com www.ahdubai.com
More informationImpact of Massachusetts Health Care Reform on Racial, Ethnic and Socioeconomic Disparities in Cardiovascular Care
Impact of Massachusetts Health Care Reform on Racial, Ethnic and Socioeconomic Disparities in Cardiovascular Care Michelle A. Albert MD MPH Treacy S. Silbaugh B.S, John Z. Ayanian MD MPP, Ann Lovett RN
More informationThe prevalence of diabetes mellitus in patients requiring
REPORT FROM STS WORKFORCE ON EVIDENCE BASED SURGERY The Society of Thoracic Surgeons Practice Guideline Series: Blood Glucose Management During Adult Cardiac Surgery Harold L. Lazar, MD, Marie McDonnell,
More informationZhongmin Li, PhD University of California, Davis School of Medicine Zhongmin.li@ucdmc.ucdavis.edu
Zhongmin Li, PhD University of California, Davis School of Medicine Zhongmin.li@ucdmc.ucdavis.edu 1 Health care quality and transparency of care and outcomes AHRQ s IQI and PSIs State initiatives Multiple
More informationInpatient Anticoagulation Safety. To provide safe and effective anticoagulation therapy through a collaborative approach.
Inpatient Anticoagulation Safety Purpose: Policy: To provide safe and effective anticoagulation therapy through a collaborative approach. Upon the written order of a physician, Heparin, Low Molecular Weight
More informationDCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study
DCCT and EDIC: The Diabetes Control and Complications Trial and Follow-up Study National Diabetes Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What
More informationDescription of the OECD Health Care Quality Indicators as well as indicator-specific information
Appendix 1. Description of the OECD Health Care Quality Indicators as well as indicator-specific information The numbers after the indicator name refer to the report(s) by OECD and/or THL where the data
More informationPOAC CLINICAL GUIDELINE
POAC CLINICAL GUIDELINE Acute Pylonephritis DIAGNOSIS COMPLICATED PYELONEPHRITIS EXCLUSION CRITERIA: Male Known or suspected renal impairment (egfr < 60) Abnormality of renal tract Known or suspected renal
More informationCARDIOLOGY ROTATION GOALS AND OBJECTIVES
CARDIOLOGY ROTATION GOALS AND OBJECTIVES PGY-1 Core Medicine Rotation The trainee will have the opportunity to develop clinical skills, the ability to analyze patients problems, and make treatment plans
More informationJill Malcolm, Karen Moir
Evaluation of Fife- DICE: Type 2 diabetes insulin conversion Article points 1. Fife-DICE is an insulin conversion group education programme. 2. People with greater than 7.5% on maximum oral therapy are
More informationHA Territory-wide PCI Audit 2003-05
HA Territory-wide PCI Audit 23-5 5 PCI Audit Working Group Central Committee (Cardiac Services) HA Convention 26 Percutaneous Coronary Intervention Background HA AP target 2/3, coordinated by PCI Working
More informationPrescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital
Research Article Prescription Pattern of Anti Hypertensive Drugs used in Hypertensive Patients with Associated Type2 Diabetes Mellitus in A Tertiary Care Hospital *T. JANAGAN 1, R. KAVITHA 1, S. A. SRIDEVI
More informationSaint Francis Kidney Transplant Program Issue Date: 6/9/15
Kidney Transplant Candidate Informed Consent Education Here are educational materials about Kidney Transplant. Please review and read these before your evaluation visit. The RN Transplant Coordinator will
More informationProvision of Intravenous EDTA Chelation as a Complementary and Alternative Medicine
Provision of Intravenous EDTA Chelation as a Complementary and Alternative Medicine Guideline Updated: August 2010 Replaced: November 1998 To serve the public and guide the medical profession EDTA Chelation
More informationEFFIMET 1000 XR Metformin Hydrochloride extended release tablet
BRAND NAME: Effimet XR. THERAPEUTIC CATEGORY: Anti-Diabetic PHARMACOLOGIC CLASS: Biguanides EFFIMET 1000 XR Metformin Hydrochloride extended release tablet COMPOSITION AND PRESENTATION Composition Each
More informationMEDICAL COVERAGE POLICY. SERVICE: Insulin Pump and Continuous Glucose Monitoring. PRIOR AUTHORIZATION: Required. POLICY:
Important note Even though this policy may indicate that a particular service or supply may be considered covered, this conclusion is not based upon the terms of your particular benefit plan. Each benefit
More information